Latest news about Bitcoin and all cryptocurrencies. Your daily crypto news habit.
Press Release
- Health brands GlycanAge, Vita Authentica and Peptide Bioregulator now accept Rejuve.AI’s RJV token payments on their platforms, helping Rejuve.AI to develop new drugs, therapies, and treatments, exclusively for longevity
- These partnerships demonstrate a real shift towards crypto payments as a preference within the wellness and longevity industries
Rejuve.AI, the world's first decentralized AI longevity research network, has announced that three new wellness brands now use Rejuve.AI’s RJV crypto token as a form of payment on their platforms. This means that GlycanAge, Vita Authentica and Peptide Bioregulator customers can now use RJV tokens as an alternative to their normal payment method.
RJV tokens are earnt by contributing health data that helps scientists to develop new drugs, therapies, and treatments, contributing to humanity’s longevity. Members can then use their earned RJV tokens for significant discounts on various products and services, as well as vouchers. This ensures that consumer contributions directly translate into tangible benefits.
GlycanAge, Vita Authentica and Peptide Bioregulator have chosen to onboard RJV tokens as they have recognised the value this cutting-edge longevity research could have on humanity. Rejuve.AI is the first of its kind, on a mission to extend healthy human life by collecting data and democratizing for research, while keeping this data secure, and this is something the three health brands want to support and contribute to.
The three recent signings to the RJV token show a shift in interest to crypto payments within the wellness and longevity industries. Rejuve.AI now has four partners who allow customers to use RJV tokens for payment and they predict they will see this grow as other brands realise the power crypto has in furthering health research.
These partnerships are just one part of a wider success story for Longevity app creator, Rejuve.AI. After raising $3.5 million in funding in 2023 alone, the organisation is now partnering with new brands across the wellness and longevity industry to help humanity live longer. As part of the SingularityNET ecosystem, Rejuve.AI is part of a group of wider AI researchers coming together to create a positive future for all.
Jasmine Smith, CEO of Rejuve.AI stated, "We are incredibly excited to announce more brands are choosing to offer the RJV tokens as a form of payment on their platform. It’s great to see more of the industry understand the important part that crypto has to play in health and longevity research over the coming years.”
GlycanAge is a leading researcher within the longevity space, as it developed the world’s first commercial glycan-based biological age test. It was also one of the first partners of Rejuve.AI and this recent agreement to bring on token payments shows the next stage in this important strategic partnership.
The second organisation to recently bring on Rejuve.AI’s RJV token is Vita Autentica. The Canadian wellness product platform allows customers to choose from nourishing supplements and vitamins to beneficial herbs, essential nutrients, and even mushrooms. Thirdly was Peptide Bioregulator, a high-quality supplement company, whose customers can now also use RJV tokens to pay for one of their 11 lab-tested formulas combing three and five peptides for maximum efficiency.
Smith continued “By partnering with such leading brands, we are able to progress towards our mission statement and deliver ground-breaking longevity research and innovation. As we see more data come in from the tokens, we’ll be able to work towards a healthy future for humanity and I’m so glad we have these businesses on the journey with us.”
If you are interested in learning more about RJV tokens and how you can start to earn these, check out more information here: https://www.rejuve.ai/tokens
Disclaimer
The views and opinions expressed in this article are solely those of the authors and do not reflect the views of Bitcoin Insider. Every investment and trading move involves risk - this is especially true for cryptocurrencies given their volatility. We strongly advise our readers to conduct their own research when making a decision.